Chemotherapy for gliomas in mainland China: An overview

Oncology Letters

Volumn 5, Issue 5, 2013, Pages 1448-1452

  Sai, Ke ^a   Yang, Qun Ying ^a   Shen, Dong ^a   Chen, Zhong Ping ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Chemotherapy; Glioma; Mainland China

Indexed keywords

CARMUSTINE; EPIPODOPHYLLOTOXIN; LOMUSTINE; NIMUSTINE; SEMUSTINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CHEMOTHERAPY; CHINA; DRUG EFFICACY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGY; PROGRESSION FREE SURVIVAL; PUBLICATION; SCIENTIFIC LITERATURE; SCORING SYSTEM; TOXICITY; TUMOR RECURRENCE;

EID: 84875718417     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1264     Document Type: Article

References (22)

1. Schwartzbaum JA, Fisher JL, Aldape KD and WrenschM: Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494-503; quiz 1 p following 516, 2006.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
3. Minniti G, Muni R, Lanzetta G, Marchetti P and EnriciRM: Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res 29: 5171-5184, 2009.
4. Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12: 2013-2021, 1994.
5. Yung WK, Prados MD, Yaya-Tur R, et al: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17: 2762-2771, 1999.
6. Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
7. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002.
8. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
9. Hart MG, Grant R, Garside R, Rogers G, Somerville M and Stein K: Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev CD007294, 2011.
10. Friedman HS, Prados MD, Wen PY, et al: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. JClin Oncol 27: 4733-4740, 2009.
11. Tianjin Medical School Affliated Hospital: Preliminary study on BCNU in the treatment of intracranial tumors: report of 45 cases. Tianjin Med J 15: 26-28, 1973 (In Chinese).
12. The First Affliated Hospital to Suzhou Medical School: Preliminary observation of treating gliomas in central nervous system with CCNU. Chin J Nerv Ment Dis 1: 51-53, 1975 (In Chinese).
13. Zeng X and Yang S: Clinical observation in chemotherapy with temozolomide alone in postoperative malignant primary cerebral glioma. Mod J Neurol Neurosurg 3: 270-273, 2003.
14. Newton HB: Intra-arterial chemotherapy of primary brain tumors. Curr Treat Options Oncol 6: 519-530, 2005.
15. Tyler JL, Yamamoto YL, Diksic M, et al: Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET. J Nucl Med 27: 775-780, 1986.
16. Shapiro WR, Green SB, Burger PC, et al: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772-781, 1992.
17. Westphal M, Hilt DC, Bortey E, et al: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5: 79-88, 2003.
18. Lin Y, Chen W, Zhuge Q, et al: Combined CT-guided stereotactic interstitial radiotherapy of 32P and MTX chemotherapy for treatment of deep brain gliomas. Chin J Neurosurg 12: 216-218, 1996 (In Chinese).
19. Qi S and Qiu B: Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy. Zhonghua Zhong Liu Za Zhi 26: 58-61, 2004 (In Chinese).
20. Li A, Zhang X, Yi Y, et al: Interstitial chemotherapy for malignant chemotherapy. Chin J Clin Neurosurg 4: 24-26, 1999 (In Chinese).
21. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30: 10-14, 2003.
22. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, WenPY and Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193, 2010.